Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 8 (21), e013091

Association Between Renal Function and Troponin T Over Time in Stable Chronic Kidney Disease Patients

Collaborators, Affiliations

Association Between Renal Function and Troponin T Over Time in Stable Chronic Kidney Disease Patients

Nicholas C Chesnaye et al. J Am Heart Assoc.


Background People with reduced glomerular filtration rate (GFR) often have elevated cardiac troponin T (cTnT) levels. It remains unclear how cTnT levels develop over time in those with chronic kidney disease (CKD). The aim of this study was to prospectively study the association between cTnT and GFR over time in older advanced-stage CKD patients not on dialysis. Methods and Results The EQUAL (European Quality Study) study is an observational prospective cohort study in stage 4 to 5 CKD patients aged ≥65 years not on dialysis (incident estimated GFR, <20 mL/min/1.73 m²). The EQUAL cohort used for the purpose of this study includes 171 patients followed in Sweden between April 2012 and December 2018. We used linear mixed models, adjusted for important groups of confounders, to investigate the effect of both measured GFR and estimated GFR on high-sensitivity cTnT (hs-cTnT) trajectory over 4 years. Almost all patients had at least 1 hs-cTnT measurement elevated above the 99th percentile of the general reference population (≤14 ng/L). On average, hs-cTnT increased by 16%/year (95% CI, 13-19; P<0.0001). Each 15 mL/min/1.73 m2 lower mean estimated GFR was associated with a 23% (95% CI, 14-31; P<0.0001) higher baseline hs-cTnT and 9% (95% CI, 5-13%; P<0.0001) steeper increase in hs-cTnT. The effect of estimated GFR on hs-cTnT trajectory was somewhat lower than a previous myocardial infarction (15%), but higher than presence of diabetes mellitus (4%) and male sex (5%). Conclusions In CKD patients, hs-cTnT increases over time as renal function decreases. Lower CKD stage (each 15 mL/min/1.73 m2 lower) is independently associated with a steeper hs-cTnT increase over time in the same range as other established cardiovascular risk factors.

Keywords: cardiorenal syndrome; renal disease; renal function; troponin T.


Figure 1
Figure 1
Patient hs‐cTn T measurements and modeled trajectories, color‐coded by eGFR. The population average trajectory is given in black. eGFR indicates estimated glomerular filtration rate; hs‐cTnT, high‐sensitivity cardiac troponin T.
Figure 2
Figure 2
The unadjusted effect of mean eGFR (mL/min/1.73 m2) on hs‐cTn T trajectory.

Similar articles

See all similar articles


    1. Giannitsis E, Katus HA. Cardiac troponin level elevations not related to acute coronary syndromes. Nat Rev Cardiol. 2013;10:623–634. - PubMed
    1. Kozinski M, Krintus M, Kubica J, Sypniewska G. High‐sensitivity cardiac troponin assays: from improved analytical performance to enhanced risk stratification. Crit Rev Clin Lab Sci. 2017;54:143–172. - PubMed
    1. Stacy SR, Suarez‐Cuervo C, Berger Z, Wilson LM, Yeh HC, Bass EB, Michos ED. Role of troponin in patients with chronic kidney disease and suspected acute coronary syndrome: a systematic review. Ann Intern Med. 2014;161:502–512. - PubMed
    1. Fridén V, Starnberg K, Muslimovic A, Ricksten SE, Bjurman C, Forsgard N, Wickman A, Hammarsten O. Clearance of cardiac troponin T with and without kidney function. Clin Biochem. 2017;50:468–474. - PubMed
    1. Chung JZY, Jones GRD. Effect of renal function on serum cardiac troponin T—population and individual effects. Clin Biochem. 2015;48:807–810. - PubMed